Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Use of l-Arginine in the Management of Pre-Eclampsia and Intrauterine Growth Restriction.

Literature DB >> 23372281

The Use of l-Arginine in the Management of Pre-Eclampsia and Intrauterine Growth Restriction.

C V Hegde¹.

Abstract

Entities: Chemical Disease

Year: 2012 PMID： 23372281 PMCID： PMC3366568 DOI： 10.1007/s13224-012-0146-8

Source DB: PubMed Journal: J Obstet Gynaecol India ISSN： 0975-6434

× No keyword cloud information.

16 in total

1. Evidence Supporting a Beneficial Role for Long-Term L-Arginine Supplementation in High-Risk Pregnancies.

Authors: Alfredo M Germain; Gloria Valdés; Mary Carmen Romanik; M Soledad Reyes
Journal: Hypertension Date: 2004-07 Impact factor: 10.190

2. Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension.

Authors: V M Campese; M Amar; C Anjali; T Medhat; A Wurgaft
Journal: J Hum Hypertens Date: 1997-08 Impact factor: 3.012

3. Plasma growth hormone after arginine infusion. Clinical experiences.

Authors: T J Merimee; D Rabinowitz; L Riggs; J A Burgess; D L Rimoin; V A McKusick
Journal: N Engl J Med Date: 1967-02-23 Impact factor: 91.245

Review 4. Nitric oxide, the endothelium, pregnancy and pre-eclampsia.

Authors: N H Morris; B M Eaton; G Dekker
Journal: Br J Obstet Gynaecol Date: 1996-01

Review 5. The clinical pharmacology of L-arginine.

Authors: R H Böger; S M Bode-Böger
Journal: Annu Rev Pharmacol Toxicol Date: 2001 Impact factor: 13.820

6. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia.

Authors: K Rytlewski; R Olszanecki; R Korbut; Z Zdebski
Journal: Eur J Clin Invest Date: 2005-01 Impact factor: 4.686

7. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.

Authors: Makrina D Savvidou; Aroon D Hingorani; Dimitrios Tsikas; Jürgen C Frölich; Patrick Vallance; Kypros H Nicolaides
Journal: Lancet Date: 2003-05-03 Impact factor: 79.321

The Use of l-Arginine in the Management of Pre-Eclampsia and Intrauterine Growth Restriction.

1. Evidence Supporting a Beneficial Role for Long-Term L-Arginine Supplementation in High-Risk Pregnancies.

2. Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension.

3. Plasma growth hormone after arginine infusion. Clinical experiences.

Review 4. Nitric oxide, the endothelium, pregnancy and pre-eclampsia.

Review 5. The clinical pharmacology of L-arginine.

6. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia.

7. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.

8. Dietary supplementation with L-arginine or placebo in women with pre-eclampsia.

9. Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine).

10. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man.

Review 1. Low Birth Weight, Blood Pressure and Renal Susceptibility.